A novel method for detection of HBVcccDNA in hepatocytes using rolling circle amplification combined with in situ PCR

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Zhong, Yanwei ^a   Hu, Shuangye ^a   Xu, Chen ^a   Zhao, Yulai ^a   Xu, Dongping ^a   Zhao, Yanqing ^a   Zhao, Jingmin ^a   Li, Zhibin ^a   Zhang, Xiuchang ^b   Zhang, Hongfei ^a   Li, Jin ^a  

^a BEIJING 302 HOSPITAL   (China)

^b Hebeinorth University   (China)

Author keywords

Covalently closed circular DNA; Hepatitis B virus; In situ PCR; Rolling circle amplification

Indexed keywords

CIRCULAR DNA; CLOSED CIRCULAR DNA; DEOXYRIBONUCLEASE; DEOXYRIBONUCLEASE I; DIGOXIGENIN; PLASMID SAFE ATP DEPENDENT DNASE; PRIMER DNA; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA TEMPLATE; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIMIT OF DETECTION; LIVER; LIVER BIOPSY; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; POLYMERASE CHAIN REACTION; ROLLING CIRCLE AMPLIFICATION; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION; VIRUS REPLICATION; EVALUATION STUDY; GENETICS; HEPATITIS B; MIDDLE AGED; PROCEDURES; VIROLOGY;

DNA PRIMERS; DNA, CIRCULAR; DNA, VIRAL; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATOCYTES; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84924287298     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-014-0608-y     Document Type: Article

References (31)

1. Hosaka T, Suzuki F, Kobayashi M, Seko Y, Kawamura Y, Sezaki H, Akuta N, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Kumada H: Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection. Hepatology 2013, 58(1):98-107.
2. Zhong Y, Lv J, Li J, Xing X, Zhu H: Prevalence, virology and antiviral drugs susceptibility of hepatitis B virus rtN238H polymerase mutation from 1865 Chinese patients with chronic hepatitis B. Antiviral Res 2012, 93:185-190.
3. Zhong YW, Li J, Song HB, Duan ZP, Dong Y: Virologic and clinical characteristics of HBV genotypes/subgenotypes in 487 Chinese pediatric patients with CHB. BMC Infect Dis 2011, 11:262.
4. Lin YJ, Lee MH, Yang HI, Jen CL, You SL: Predictability of liver-related Seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients. PLoS One 2013, 8(4):e61448. doi:10.1371.
5. Locarnini S, Hatzakis A, Heathcote J, Keeffe EB, Liang TJ: Management of antiviral resistance in patients with chronic hepatitis B. Antivir Ther 2004, 9:679-693.
6. Seeger C, Mason WS: Hepatitis B virus biology. Microbiol Mol Biol Rev 2000, 64:51-68.
7. Pawlotsky JM, Dusheiko G, Hatzakis A, Lau D, Lau G: Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized. Gastroenterology 2008, 134:405-415.
8. Werle-Lapostolle B, Bowden S, Locarnini S, Wursthorn K, Petersen J: Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 2004, 126:1750-1758.
9. Lenci I, Marcuccilli F, Tisone G, Di Paolo D, Tariciotti L: Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis. Dig Liver Dis 2010, 42:578-584.
10. Lu L, Zhang HY, Yueng YH, Cheung KF, Luk JM: Intracellular levels of hepatitis B virus DNA and pregenomic RNA in peripheral blood mononuclear cells of chronically infected patients. J Viral Hepat 2009, 16:104-112.
11. Wong DK, Yuen MF, Yuan H, Sum SS, Hui CK: Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients. Hepatology 2004, 40:727-737.
12. Laras A, Koskinas J, Dimou E, Kostamena A, Hadziyannis SJ: Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients. Hepatology 2006, 44:694-702.
13. Wursthorn K, Lutgehetmann M, Dandri M, Volz T, Buggisch P: Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology 2006, 44:675-684.
14. Zhong Y, Han J, Zou Z, Liu S, Tang B: Quantitation of HBV covalently closed circular DNA in micro formalin fixed paraffin-embedded liver tissue using rolling circle amplification in combination with real-time PCR. Clin Chim Acta 2012, 412:1905-1911.
15. Bowden S, Jackson K, Littlejohn M, Locarnini S: Quantification of HBV covalently closed circular DNA from liver tissue by real-time PCR. Methods Mol Med 2004, 95:41-50.
16. Singh M, Dicaire A, Wakil AE, Luscombe C, Sacks SL: Quantitation of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in the liver of HBV-infected patients by LightcyclerTM real-time PCR. J Virol Methods 2004, 118:159-167.
17. Takkenberg RB, Zaaijer HL, Menting S, Weegink CJ, Terpstra V: Detection of hepatitis B virus covalently closed circular DNA in paraffin-embedded and cryo-preserved liver biopsies of chronic hepatitis B patients. Eur J Gastroenterol Hepatol 2010, 22:952-960.
18. Zhang DY, Brandwein M, Hsuih T, Li HB: Ramification amplification: a novel isothermal DNA amplification method. Mol Diagn 2001, 6:141-150.
19. Lasken RS, Egholm M: Whole genome amplification: abundant supplies of DNA from precious samples or clinical specimens. Trends Biotechnol 2003, 21:531-535.
20. Margeridon S, Carrouee-Durantel S, Chemin I, Barraud L, Zoulim F: Rolling circle amplification, a powerful tool for genetic and functional studies of complete hepatitis B virus genomes from low-level infections and for directly probing covalently closed circular DNA. Antimicrob Agents Chemother 2008, 52:3068-3073.
21. Su HL, Liu YM, Ren XQ, Xu DP, Zhong YW: Comparative analysis of drug resistant mutations in the reverse transcriptase domain of hepatitis B virus covalently closed circular DNA and the viral relax circle DNA. Chin J Hepatol 2010, 8:818-821.
22. Johne R, Muller H, Rector A, van Ranst M, Stevens H: Rolling-circle amplification of viral DNA genomes using phi29 polymerase. Trends Microbiol 2009, 17:205-211.
23. Haase AT, Retzel EF, Staskus KA: Amplification and detection of lentiviral DNA inside cells. Proc Natl Acad Sci U S A 1990, 87:4971-4975.
24. Shieh B, Lee SE, Tsai YC, Su IJ, Li C: Detection of hepatitis B virus genome in hepatocellular carcinoma tissues with PCR-in situ hybridization. J Virol Methods 1990, 80:157-167.
25. Alzahrani AJ, Vallely PJ, McMahon RF: Development of a novel nested in situ PCR-ISH method for detection of hepatitis C virus RNA in liver tissue. J Virol Methods 2002, 99:53-61.
26. Nuriya H, Inoue K, Tanaka T, Hayashi Y, Hishima T: Detection of hepatitis B and C viruses in almost all hepatocytes by modified PCR-based in situ hybridization. J Clin Microbiol 2010, 48:3843-3851.
27. Asan E: Progress in focus: recent advances in histochemistry and cell biology. Histochem Cell Biol 2002, 118:507-525.
28. Nuovo GJP: The utility of in situ-based methodologies including in situ polymerase chain reaction for the diagnosis and study of viral infections. Hum Pathol 2007, 38:1123-1136.
29. Teo IA, Shaunak S: Polymerase chain reaction in situ: an appraisal of an emerging technique. Histochem J 1995, 27:647-659.
30. Nuovo GJ, Gallery F, Hom R, MacConnell P, Bloch W: Importance of different variables for enhancing in situ detection of PCR-amplified DNA. PCR Methods Appl 1993, 2:305-312.
31. Zaki SR, Heneine W, Coffield LM, Greer PW, Sinha SD: In-situ polymerase chain reaction amplification: applications and current limitations. AIDS 1994, 8:1186-1187.